These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8868304)

  • 1. Dopamine inhibits in vitro release of VIP and proliferation of VIP-immunoreactive pituitary cells.
    Carretero J; Vazquez RJ; Santos M; Cacicedo L; Rubio M; Sanchez-Franco F; Vazquez R
    Neuropeptides; 1996 Feb; 30(1):81-6. PubMed ID: 8868304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreases in the size and proliferation rate of VIP-immunoreactive cells induced in vitro by testosterone are associated with decreases in VIP release.
    Carretero J; Rubio M; Vázquez-Perfecto RJ; Sánchez F; Torres JL; Pérez RM; Vázquez R
    Neuroendocrinology; 1997 Mar; 65(3):173-8. PubMed ID: 9087998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity and proliferation of pituitary prolactin-positive cells and pituitary VIP-positive cells are regulated by interleukin 6.
    Blanco EJ; Carretero-Hernández M; García-Barrado J; Iglesias-Osma MC; Carretero M; Herrero JJ; Rubio M; Riesco JM; Carretero J
    Histol Histopathol; 2013 Dec; 28(12):1595-604. PubMed ID: 23700204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro immunoblockade of VIP inhibits the proliferation of pituitary prolactin cells.
    Carretero J; Angoso M; Rubio M; Blanco EJ; Sierra E; Herrero JJ; Pérez E; Burks DJ
    Anat Embryol (Berl); 2006 Jan; 211(1):11-8. PubMed ID: 16328361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro morphometric and proliferative variations in VIP-immunoreactive pituitary cells induced by estradiol.
    Carretero J; Rubio M; Sánchez F; Vázquez RJ; Santos M; Blanco J; Vázquez R
    Neuroendocrinology; 1995 Sep; 62(3):277-82. PubMed ID: 8538865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evidence for direct dopaminergic inhibition of VIP-immunoreactive pituitary cells.
    Carretero J; Sanchez F; Rubio M; Francos CM; Blanco J; Vazquez R
    Neuropeptides; 1994 Jul; 27(1):1-6. PubMed ID: 7969815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of estradiol on pituitary GH-immunoreactive cells.
    Carretero J; Rubio M; Sánchez F; Pereña J; Estévez FI; Vázquez G; Pérez RM; Vázquez R
    Histol Histopathol; 1997 Jul; 12(3):631-6. PubMed ID: 9225144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of pituitary vasoactive intestinal peptide in dopaminergic inhibition of estrogen-induced pituitary hyperplasia and vascular endothelial growth factor expression.
    Gómez O; Balsa JA
    Neuroendocrinology; 2004; 80(5):324-31. PubMed ID: 15677882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide.
    Escalada J; Cacicedo L; Ortego J; Melian E; Sánchez-Franco F
    Endocrinology; 1996 Feb; 137(2):631-7. PubMed ID: 8593812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen.
    Gómez O; Balsa JA
    Endocrinology; 2003 Oct; 144(10):4403-9. PubMed ID: 12960047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of immunoreactive vasoactive intestinal polypeptide in anterior pituitary of normal male and long term estrogen-treated female rats: a light microscopic immunohistochemical study.
    Köves K; Gottschall PE; Görcs T; Scammell JG; Arimura A
    Endocrinology; 1990 Mar; 126(3):1756-63. PubMed ID: 1689657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
    Apfelbaum ME
    Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influences of GnRH, oxytocin and vasoactive intestinal peptide on LH and PRL secretion by porcine pituitary cells in vitro.
    Bogacka I; Siawrys G; Okrasa S; Kaminski T; Przala J
    J Physiol Pharmacol; 2002 Sep; 53(3):439-51. PubMed ID: 12369740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of vasoactive intestinal peptide on insulin-like growth factor I-induced proliferation of rat pituitary lactotropes in primary culture: evidence for an autocrine and/or paracrine regulatory system.
    Fernández M; Sánchez-Franco F; Palacios N; Sánchez I; Villuendas G; Cacicedo L
    Neuroendocrinology; 2003 May; 77(5):341-52. PubMed ID: 12806180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential increase in pituitary prolactin versus vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat.
    Carrillo AJ; Doherty PC; Guan XB; Sturtevant JR; Walro DG
    Endocrinology; 1991 Jan; 128(1):131-8. PubMed ID: 1986914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulatory action of estrogen and vasoactive intestinal peptide on prolactin secretion in sea bream (Sparus aurata, L.).
    Brinca L; Fuentes J; Power DM
    Gen Comp Endocrinol; 2003 Apr; 131(2):117-25. PubMed ID: 12679088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide stimulation of human trabecular meshwork cell growth.
    Koh SW; Yeh TH; Morris SM; Leffler M; Higginbotham EJ; Brenneman DE; Yue BY
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2781-9. PubMed ID: 9418731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related changes in rates of basal secretion of immunoreactive vasoactive intestinal polypeptide and dopamine into pituitary stalk blood from the hypothalamus in anesthetized male rats.
    Hotta H; Ito H; Matsuda K; Sato A; Tohgi H
    Jpn J Physiol; 1991; 41(2):317-25. PubMed ID: 1942666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study.
    Hsu DW; Riskind PN; Hedley-Whyte ET
    Am J Pathol; 1989 Aug; 135(2):329-38. PubMed ID: 2782377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.